Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Jazmin, Schwartz"'
Autor:
Ivan J. Cohen, Fresia Pareja, Nicholas D. Socci, Ronglai Shen, Ashley S. Doane, Jazmin Schwartz, Raya Khanin, Elizabeth A. Morris, Elizabeth J. Sutton, Ronald G. Blasberg
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Response to immunotherapy across multiple cancer types is approximately 25%, with some tumor types showing increased response rates compared to others (i.e. response rates in melanoma and non-small cell lung cancer (NSCLC) are typically 30-60%). Pati
Externí odkaz:
https://doaj.org/article/b6d4c2779f6e4c78b8dc4b87286d952c
Autor:
Nicola Naydenov, Alexei Teplov, Mahdi Zadeh Zirakchian, Shutian Ruan, Bae P. Chu, Brian Serencsits, Marisa Iraca, Olga Talarico, Brian Miller, Henry Kunin, Jazmin Schwartz, Adam Kesner, Lars R. Furenlid, Larry Dauer, Yukako Yagi, John L. Humm, Pat Zanzonico, Constantinos T. Sofocleous, Assen S. Kirov
Publikováno v:
Journal of Vascular and Interventional Radiology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2efa4b34fbb3d4640dad5a88a62f5f31
https://doi.org/10.1016/j.jvir.2023.05.022
https://doi.org/10.1016/j.jvir.2023.05.022
Autor:
Simone, Krebs, Jazmin, Schwartz, Christian, Grommes, Robert J, Young, Heiko, Schöder, Marius, Mayerhoefer
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a743c69626d9211ac6dbf04773681c8f
https://pubmed.ncbi.nlm.nih.gov/36357178
https://pubmed.ncbi.nlm.nih.gov/36357178
Autor:
Joseph J. Fox, Heiko Schöder, Åse Ballangrud, Yize Zhao, Anthony F. Yu, Jazmin Schwartz, Alice Y. Ho, Simon N. Powell, Henry W. Strauss, Sadek Nehmeh, Dipti Gupta
Publikováno v:
Clinical Imaging. 68:283-290
Objective (1) Assess the feasibility of 13 N-ammonia cardiac PET (13 N-ammonia-PET) imaging in radiotherapy (RT) treatment position in locally-advanced breast cancer (LABC) patients. (2) Correlate pre−/post-RT changes in myocardial flow reserve (MF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e8c687489f68ffd1d86fddcf5802096
https://doi.org/10.1016/j.clinimag.2020.07.026
https://doi.org/10.1016/j.clinimag.2020.07.026
Autor:
Aaron W. P. Maxwell, Humberto G. Mendoza, Matthew J. Sellitti, Juan C. Camacho, Amy R. Deipolyi, Etay Ziv, Constantinos T. Sofocleous, Hooman Yarmohammadi, Majid Maybody, John L. Humm, Jazmin Schwartz, Krishna Juluru, Mark P. Dunphy, F. Edward Boas
Publikováno v:
Cardiovasc Intervent Radiol
PURPOSE: To determine how particle density affects dose distribution and outcomes after lobar radioembolization. METHODS: Matched pairs of patients, treated with glass versus resin microspheres, were selected by propensity score matching (114 patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::587dda3e3497a49dfdff609e7bf70212
https://europepmc.org/articles/PMC10103908/
https://europepmc.org/articles/PMC10103908/
Autor:
Aaron W P, Maxwell, Humberto G, Mendoza, Matthew J, Sellitti, Juan C, Camacho, Amy R, Deipolyi, Etay, Ziv, Constantinos T, Sofocleous, Hooman, Yarmohammadi, Majid, Maybody, John L, Humm, Jazmin, Schwartz, Krishna, Juluru, Mark P, Dunphy, F Edward, Boas
Publikováno v:
Cardiovascular and interventional radiology. 45(7)
To determine how particle density affects dose distribution and outcomes after lobar radioembolization.Matched pairs of patients, treated with glass versus resin microspheres, were selected by propensity score matching (114 patients), in this single-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c1669d70bde6fa7d86104468017760ed
https://pubmed.ncbi.nlm.nih.gov/35641607
https://pubmed.ncbi.nlm.nih.gov/35641607
Autor:
Aaron W. P. Maxwell, Humberto G. Mendoza, Matthew J. Sellitti, Juan C. Camacho, Amy R. Deipolyi, Etay Ziv, Constantinos T. Sofocleous, Hooman Yarmohammadi, Majid Maybody, John L. Humm, Jazmin Schwartz, Krishna Juluru, Mark P. Dunphy, F. Edward Boas
Publikováno v:
CardioVascular and Interventional Radiology. 45:1055-1055
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ada1e001e4f5fffc95aa16bd362bfaaf
https://doi.org/10.1007/s00270-022-03171-6
https://doi.org/10.1007/s00270-022-03171-6
Autor:
Sheryl Roberts, Nelson S Moss, Robert J. Young, Anna F. Piotrowski, Christopher C. Riedl, Susanne Kossatz, Jazmin Schwartz, Serge K. Lyashchenko, Paula Demétrio De Souza França, Audrey Mauguen, Mark Dunphy, Eva M Burnaz, Thomas Reiner, Megan Fiasconaro, Alexandra Miller, Philip J. Nicklin, Giacomo Pirovano, Tejus Bale, Patrick L. Donabedian, Zhigang Zhang
We report pre-clinical and first-in-human-brain-cancer data using a targeted poly(ADP-ribose)polymerase1 (PARP1) binding PET tracer, [18F]PARPi, as a diagnostic tool to differentiate between brain cancers and treatment related changes. In a pre-clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3800ccd476d550f95540cf9f294341c4
https://doi.org/10.1101/2020.07.13.20141036
https://doi.org/10.1101/2020.07.13.20141036
Autor:
Sadek A, Nehmeh, Joseph J, Fox, Jazmin, Schwartz, Åse M, Ballangrud, Heiko, Schöder, Yize, Zhao, Henry W, Strauss, Anthony, Yu, Dipti, Gupta, Simon N, Powell, Alice Y, Ho
Publikováno v:
Clin Imaging
OBJECTIVE: (1) Assess the feasibility of 13 N-ammonia cardiac PET (13 N-ammonia-PET) imaging in radiotherapy (RT) treatment position in locally-advanced breast cancer (LABC) patients. (2) Correlate pre – /post-RT changes in myocardial flow reserve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8657fd20c0499b0b956704e5abc7f07f
https://pubmed.ncbi.nlm.nih.gov/32919154
https://pubmed.ncbi.nlm.nih.gov/32919154
Autor:
Alexandra Miller, Patrick L. Donabedian, Audrey Mauguen, Giacomo Pirovano, Serge K. Lyashchenko, Sheryl Roberts, Nelson S Moss, Jazmin Schwartz, Thomas Reiner, Zhigang Zhang, Susanne Kossatz, Robert J. Young, Anna F. Piotrowski, Philip J. Nicklin, Christopher C. Riedl, Megan Fiasconaro, Eva Burnazi, Mark Dunphy, Tejus Bale, Paula Demétrio De Souza França
Publikováno v:
Neuro-oncology Advances
Background We report preclinical and first-in-human-brain-cancer data using a targeted poly (ADP-ribose) polymerase 1 (PARP1) binding PET tracer, [18F]PARPi, as a diagnostic tool to differentiate between brain cancers and treatment-related changes. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d8824c7c6fc4b31ffcd18769ab1328b
https://doi.org/10.1093/noajnl/vdaa119
https://doi.org/10.1093/noajnl/vdaa119